|Articles|May 4, 2006

2006 Conference Statistics

Author(s)BioPharm International Editors

Data from recent Biotech/Pharmaceutical Industry Conference/Events

To view a PDF of this article from the BioPharm International archives, click this link

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!

Related Content

Creative image of embryonic stem cells, cellular therapy. 3d illustration | Image credit: © pinkeyes - © pinkeyes - stock.adobe.co

Implementing Automation and Flexible Design for Allogeneic Manufacturing

ByJennifer Markarian

December 2nd 2025

96-well microplate | Image credit: © Caleb Foster - © Caleb Foster - stock.adobe.com

New Draft Guidance Highlights FDA Push Toward Human-Relevant Safety Models

ByFeliza Mirasol

December 2nd 2025

A man in protective clothing with test tubes in his hands against the background of a laboratory bioreactor.Experiments in the field of Microbiology. Pharmaceutical research.Synthesis of new chemicals | Image credit: © Grispb - © Grispb - stock.adobe.com

Rentschler–Coriolis Partnership Reflects Demand for Connected Biopharma Workflows

ByFeliza Mirasol

December 2nd 2025

Ampoules vaccine from coronavirus with syringe 3d render illustration on white. | © mylisa - © mylisa - stock.adobe.com

Regulatory Uncertainty Surfaces as FDA Blames COVID Vaccines for 10 Child Deaths

ByFeliza Mirasol

December 1st 2025

FAQ: What You Need to Know About How Industry is Tackling CGT Bottlenecks

ByFeliza Mirasol

November 30th 2025

2006 Conference Statistics

Newsletter

Related Content

Implementing Automation and Flexible Design for Allogeneic Manufacturing

New Draft Guidance Highlights FDA Push Toward Human-Relevant Safety Models

Rentschler–Coriolis Partnership Reflects Demand for Connected Biopharma Workflows

Regulatory Uncertainty Surfaces as FDA Blames COVID Vaccines for 10 Child Deaths

FAQ: What You Need to Know About How Industry is Tackling CGT Bottlenecks

Trending on BioPharm International

Regulatory Uncertainty Surfaces as FDA Blames COVID Vaccines for 10 Child Deaths

New Draft Guidance Highlights FDA Push Toward Human-Relevant Safety Models

Rentschler–Coriolis Partnership Reflects Demand for Connected Biopharma Workflows

Accelerating Complex Drug Development With Precision Micronization

BioPharm Weekly News Roundup—Week of Nov. 24, 2025